Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck KgaA, a German pharmaceutical and chemical company, has reported total revenues of EUR2.09bn for the first quarter 2010, an increase of 12.9%, compared to EUR1.85bn for the comparable period in 2009.
Subscribe to our email newsletter
Merck KgaA has posted a net income of EUR191.4m for the first quarter 2010, or EUR0.88 per diluted share, compared to EUR56.7, or EUR0.26 per diluted share, for the prior year period.
Operating income was EUR294.8m for the first quarter, compared to EUR198.1m for the year ago period. EBIT was EUR294.8, compared to EUR127.9m for the year ago period.
Karl-Ludwig Kley, chairman of the executive board of Merck KgaA, said: “Although we don’t expect 2010 will be easy, we did start the year off quite well, especially in our Chemicals business.
“Because of the good results in our Liquid Crystals division, we have raised our guidance for 2010 and now expect the operating result of our Liquid Crystals division to rise by 60 to 70% and the Group operating result to increase between 30 and 40%.”